Emerging therapeutic uses of direct‐acting oral anticoagulants: An evidence‐based perspective

@article{Raschi2017EmergingTU,
  title={Emerging therapeutic uses of direct‐acting oral anticoagulants: An evidence‐based perspective},
  author={E. Raschi and M. Bianchin and R. De Ponti and F. De Ponti and W. Ageno},
  journal={Pharmacological Research},
  year={2017},
  volume={120},
  pages={206–218}
}
  • E. Raschi, M. Bianchin, +2 authors W. Ageno
  • Published 2017
  • Medicine
  • Pharmacological Research
    • &NA; Direct‐acting oral anticoagulants (DOACs) were claimed to cause a potential paradigm shift in the therapeutic scenario of patients requiring short‐ and long‐term anticoagulation, by virtue of their pharmacological properties, perceived as innovative. The evidence gathered so far (from pre‐approval pivotal trials to real‐world post‐marketing observational data) consistently confirmed that DOACs are overall comparable to vitamin‐K antagonists (VKAs) in terms of safety, efficacy and… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    9 Citations
    Background Citations
    6
    9 Citations
    Citation Type

    Citation Type

    Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?
    • 4
    Pharmacokinetic drug interactions of the non‐vitamin K antagonist oral anticoagulants (NOACs)
    • 29
    Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
    • 6
    What are the Characteristics of Patients Experiencing Adverse Drug Reactions to Oral Anticogulants and How Can Such Reactions be Prevented
    • 2
    Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review
    • PDF
    ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations
    • 12
    Dosing considerations in the use of the direct oral anticoagulants in the antiphospholipid syndrome
    • 7
    Prognostic and therapeutic implications of vascular disease in patients with atrial fibrillation
    • 6
    The ups and downs of anticoagulation prescription in the United Kingdom
    • 1

    References

    SHOWING 1-10 OF 101 REFERENCES
    Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
    • 19
    Adverse events associated with the use of direct-acting oral anticoagulants in clinical practice: beyond bleeding complications.
    • 16
    • PDF
    Direct oral anticoagulants: Current indications and unmet needs in the treatment of venous thromboembolism
    • 22
    Meta‐analysis of the efficacy and safety of new oral anticoagulants in patients with cancer‐associated acute venous thromboembolism: comment
    • 104
    Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral Anticoagulants.
    • 65
    • PDF
    Efficacy and safety of anticoagulant therapy for the treatment of acute cancer-associated thrombosis: a systematic review and meta-analysis.
    • 116
    Current Clinical Trials on the Use of Direct Oral Anticoagulants in the Pediatric Population
    • 33
    • PDF
    Non-Vitamin K Antagonist Oral Anticoagulants and the Treatment of Venous Thromboembolism in Cancer Patients: A Semi Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes
    • 47
    • PDF
    Novel oral anticoagulants for heparin-induced thrombocytopenia
    • 22
    Italian intersociety consensus on DOAC use in internal medicine
    • 38
    • PDF